| Chitosan |
|
• Salt- induced phase transition |
37 |
• In situ gel-based drug delivery (ocular, wound dressing) |
110–112 and 114–116
|
| • Antibacterial property |
| • Muco-adhesiveness |
| Xyloglucan |
|
• Degalactosylation-induced phase transition |
37 |
• In situ gel-based drug delivery (nasal, stem cell) |
97–99, 121–125, 127, 135, 136 and 138
|
| • Promoting stem cell survival |
• In situ gel-based cellular scaffolds (osteogenic cell) |
| • Pseudo-plastic flow behavior |
|
| • Thermo-sensitivity |
|
| Methylcellulose |
|
• Hydrophobic interaction-based gelation |
|
• Topical drug delivery |
102, 144, 147, 153, 156 and 163
|
| • Flexible shape and geometry |
• Bone tissue regeneration |
|
• 3D cellular scaffolds |
